Q3 2025 Earnings Call Transcript November 10, 2025 Surgery Partners, Inc. misses on earnings expectations. Reported EPS is ...

Get key takeaways from Surgery Partners’ Q3 2025 earnings call, including revised guidance, market challenges, and growth strategies.

Discover why Conagra Brands, Inc. offers an attractive dividend yield and value opportunity despite recent declines. Click ...

After decades of of talking about it, these days I find myself living more and more by the Wilhelmi Element - The only price ...

Monday.Com (MNDY) stock trading flat after reporting upbeat Q3 revenues, analysts have mixed reactions on stock with varying ...

Growth has accelerated in the second half of the year -- and 2026 looks promising, too. In short, the company's latest update points to a return to a more normal growth cadence in 2026. And based on ...

APi delivered quarterly results that exceeded Wall Street’s revenue and non-GAAP profit expectations, prompting a significant ...

RBC Capital lowered the firm’s price target on Surgery Partners (SGRY) to $31 from $35 but keeps an Outperform rating on the shares after its Q3 ...

Masimo’s third quarter results for 2025 were met with a significant negative market reaction, despite the company surpassing Wall Street’s revenue and adjusted profit expectations. Management ...

RXO’s third quarter was marked by a significant margin squeeze and weaker-than-expected profitability, which led to a sharp ...

Advertising technology stock AppLovin (NASDAQ: APP) just reported its much-anticipated Q3 2025 earnings. Despite ups and ...